Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plan B Decision Mobilizes House Members To Seek FDA Integrity Review

This article was originally published in The Pink Sheet Daily

Executive Summary

A bill directing the agency to conduct a formal review of its decision-making process in turning down the Rx-to-OTC switch application for the emergency contraceptive is slated to be introduced May 13 by Rep. Maloney.

You may also be interested in...



Jenkins’ Exit Interview: He’ll Miss Insider Status Upon FDA Departure

Outgoing US FDA Office of New Drugs director tells the Pink Sheet being on the outside will take some adjustment.

Plan B GAO Investigation Sought By House Members

Group led by Rep. Waxman is requesting that GAO examine communications between the White House and HHS regarding FDA's decision not to approve the Plan B emergency contraceptive switch application.

Plan B GAO Investigation Sought By House Members

Group led by Rep. Waxman is requesting that GAO examine communications between the White House and HHS regarding FDA's decision not to approve the Plan B emergency contraceptive switch application.

Topics

UsernamePublicRestriction

Register

PS059391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel